Company intelligence / Profile preview
Gilead Sciences
Foster City, California, United Statesgilead.com ↗
- Ownership
- Public · GILD
- Employees
- ~17600
- Development stage
- Commercial
01
Overview
Gilead has a broad portfolio of commercialized products in virology—especially HIV/AIDS and viral hepatitis—and oncology. Its HIV regimens are global standards of care. Hepatitis C drugs like Sovaldi and Harvoni have achieved high cure rates. Remdesivir was the first antiviral approved for COVID‑19 treatment. In oncology/cell therapy through Kite Pharma’s Yescarta and Tecartus CAR-Ts for lymphomas/leukemias are FDA-approved[1][2][3][4][8].
- Therapeutic areas
- OncologyImmunologyInfectious Diseases
- Modalities
- Small moleculesmonoclonal antibodies (mAbs)cell therapies (CAR-T)antivirals
- Industry
- Pharma
02
Drug pipeline
232 assets231 more assets in the full pipeline.
Request access →03
Partnerships
Multiple licensing agreements with generic manufacturers for global access to antivirals[7]Collaborations with Galapagos NV in inflammation/fibrosis research[3]Academic partnerships worldwide; see below.
Beyond the preview
Go deeper on Gilead Sciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gilead Sciences.